4.8 Article

Bioelectronic cell-based device provides a strategy for the treatment of the experimental model of multiple sclerosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Economics

The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing-Remitting Multiple Sclerosis

Laurenske A. Visser et al.

Summary: The Optogenerapy consortium is developing a novel bioelectronic cell-based implant for controlled release of beta-interferon protein into the body, which has shown to be a cost-effective therapy for multiple sclerosis patients. The innovative technology of the Optoferon implant may potentially revolutionize treatment administration for MS patients and other disease areas.

PHARMACOECONOMICS (2022)

Article Biochemistry & Molecular Biology

BioUML-towards a universal research platform

Fedor Kolpakov et al.

Summary: BioUML is a web-based integrated platform for systems biology and data analysis. It supports the construction of complex biological models and offers powerful data analysis and visualization capabilities. The platform is also integrated with other tools and plugins to meet various research requirements.

NUCLEIC ACIDS RESEARCH (2022)

Review Pharmacology & Pharmacy

Cell microencapsulation technologies for sustained drug delivery: Clinical trials and companies

Tania B. Lopez-Mendez et al.

Summary: In recent years, cell microencapsulation technology has advanced significantly, driven by developments in stem cell usage and biomaterial optimization. These products are primarily used for diabetes treatment but have potential applications in other medical fields. Global key players are working to bring this technology to clinical use.

DRUG DISCOVERY TODAY (2021)

Article Biotechnology & Applied Microbiology

Optimized Protocol for Subcutaneous Implantation of Encapsulated Cells Device and Evaluation of Biocompatibility

Emilie Audouard et al.

Summary: This study investigates an innovative approach for treating central nervous system disorders by implanting a wireless-powered cell-based device. The technology allows for control over the secretion of therapeutic molecules and activation on demand. Further verification of the safety and biocompatibility of the clinical device is necessary.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Article Chemistry, Multidisciplinary

Conformable Hybrid Systems for Implantable Bioelectronic Interfaces

Florian Fallegger et al.

ADVANCED MATERIALS (2020)

Article Multidisciplinary Sciences

Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice

Krzysztof Krawczyk et al.

SCIENCE (2020)

Review Cell Biology

Molecular mechanisms and cellular functions of cGAS-STING signalling

Karl-Peter Hopfner et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Chemistry, Multidisciplinary

Devising Materials Manufacturing Toward Lab-to-Fab Translation of Flexible Electronics

Yifei Luo et al.

ADVANCED MATERIALS (2020)

Review Pharmacology & Pharmacy

Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond

Marco Farina et al.

ADVANCED DRUG DELIVERY REVIEWS (2019)

Review Biochemical Research Methods

From synthetic biology to human therapy: engineered mammalian cells

Leo Scheller et al.

CURRENT OPINION IN BIOTECHNOLOGY (2019)

Article Medicine, Research & Experimental

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe

Renske M. T. ten Ham et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Review Biochemical Research Methods

Synthetic biology-inspired therapies for metabolic diseases

Ana Palma Teixeira et al.

CURRENT OPINION IN BIOTECHNOLOGY (2017)

Article Multidisciplinary Sciences

Synthetic gene network restoring endogenous pituitary-thyroid feedback control in experimental Graves' disease

Pratik Saxena et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Medicine, Research & Experimental

Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis

Martin Marziniak et al.

ADVANCES IN THERAPY (2014)

Article Biotechnology & Applied Microbiology

Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells

Alireza Rezania et al.

NATURE BIOTECHNOLOGY (2014)

Article Multidisciplinary Sciences

NET23/STING Promotes Chromatin Compaction from the Nuclear Envelope

Poonam Malik et al.

PLOS ONE (2014)

Article Multidisciplinary Sciences

Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant

Marc Folcher et al.

NATURE COMMUNICATIONS (2014)

Article Biochemical Research Methods

Near-infrared Light Responsive Synthetic c-di-GMP Module for Optogenetic Applications

Min-Hyung Ryu et al.

ACS SYNTHETIC BIOLOGY (2014)

Article Biotechnology & Applied Microbiology

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy

F. Schwenter et al.

CANCER GENE THERAPY (2011)

Article Biochemical Research Methods

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

Mark D. Robinson et al.

BIOINFORMATICS (2010)

Article Biochemistry & Molecular Biology

Natural and Engineered Photoactivated Nucleotidyl Cyclases for Optogenetic Applications

Min-Hyung Ryu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-β enhancer

Carlos R. Escalante et al.

MOLECULAR CELL (2007)

Article Biochemistry & Molecular Biology

Mx1 and IP-10:: Biomarkers to measure IFN-β activity in mice following gene-based delivery

Harald Petry et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)